Colposcopy in comparison with HPV-Pap test for the diagnosis of Cervical ‎Intraepithelial Neoplasia 2‎

Arab, Maliheh; Moridi, Atefeh; Maktabi, Maryam; Safaei, Nazanin; Ghavami, Behnaz; Sanati, Mahdie

doi:10.30491/ijmr.2021.253604.1153

Colposcopy in comparison with HPV-Pap test for the diagnosis of Cervical ‎Intraepithelial Neoplasia 2‎

Document Type : Content Analysis

Authors

Maliheh Arab ¹

Atefeh Moridi ²

Maryam Maktabi ³

Nazanin Safaei ⁴

Behnaz Ghavami ⁴

Mahdie Sanati ⁵

¹ Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, ‎Tehran, Iran ‎

² Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, ‎Tehran, Iran

³ Arak University of Medical Sciences, Arak, Iran

⁴ Department of Obstetrics and Gynecology, Tehran University of Medical Sciences, Tehran, Iran

⁵ Department of Obstetrics and Gynecology, Tehran University of Medical Sciences, Tehran, Ir

10.30491/ijmr.2021.253604.1153

Abstract

Introduction: The effectiveness of cervical cancer screening programs is an issue of concern in developing countries. It is a goal of researchers to find another solution or screening method to solve this problem. The current study aimed to compare the cos teffectiveness of the colposcopy and HPV-Pap test approaches.
Methods: This cross-sectional study examined 1944 asymptomatic women aged 30-70 years who had undergone colposcopy from 2013-2015. The cost of finding each CIN2 case was obtained and compared with the cost of the HPV-Pap test finding.
Results: A pathology of CIN2 or greater cases were reported in 43 cases (2.2%). The cost of finding each case by colposcopy was 2,456 USD and by PCR-Pap was 2,966 USD (P<0.0001).
Conclusion: The cost of finding each CIN2 or greater case by HPV-Pap test was 1.32 times that of a colposcopy. Colposcopy in this setting was more cost-effective and should be considered in similar settings.

Keywords

Colposcopy, HPV-Pap Test, CIN2

Iran, Cost-effectiveness